Systematic evolution of ligands by exponential enrichment: tissue selex

Simple item page
dc.contributor.assigneeNeXstar Pharmaceuticals, Inc.
dc.contributor.authorJensen, K.
dc.contributor.authorChen, H.
dc.contributor.authorMorris, K.N.
dc.contributor.authorStephens, A.
dc.contributor.authorGold, L.
dc.date.issued1999
dc.descriptionPublication number US5864026 A Publication type Grant Application number US 08/437,667 Publication date Jan 26, 1999 Filing date May 3, 1995 Priority date Jun 11, 1990
dc.description.abstractThis invention discloses high-affinity oligonucleotide ligands to complex tissue targets, specifically nucleic acid ligands having the ability to bind to complex tissue targets, and the methods for obtaining such ligands. Tissue targets comprise cells, subcellular components, aggregates or cells, collections of cells, and higher ordered structures. Specifically, nucleic acid ligands to red blood cells ghosts, glioblastomas, and lymphomas are described.
dc.description.statementofresponsibilityInventors: Jensen Kirk, Chen Hang, Morris Kevin N., Stephens Andrew, Gold Larry. Assignee: NeXstar Pharmaceuticals, Inc. Agents: Swanson & Bratschun LLC
dc.identifier.orcidJensen, K. [0000-0002-2084-1734]
dc.identifier.patentUS5864026
dc.identifier.urihttp://hdl.handle.net/2440/87863
dc.language.isoen
dc.titleSystematic evolution of ligands by exponential enrichment: tissue selex
dc.typePatent
pubs.publication-statusPublished

Files

Collections

Molecular and Biomedical Science publications